Skip to content

Hepatitis C infection and reinfection among men who have sex with men need higher priority, US and European studies show

Risk of reinfection is a concern after successful hepatitis C treatment

Olav Dalgard of Akershus University Hospital presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C vaccine development shows progress but scientific barriers remain

Professor Andrea Cox of Johns Hopkins University presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.com

INHSU 2016 opens with focus on hepatitis C prevention and treatment for people who inject drugs

Holly Hagan of New York University presenting at INHSU 2016. Photo by Liz Highleyman, hivandhepatitis.com

Neglect of infectious diseases in prisons highlighted at AIDS 2016

Vaccination could have important role in control of UK HCV epidemic among people who inject drugs

Many US communities vulnerable to HIV outbreak due to unsafe injecting of prescription opioids

WHO issues new hepatitis C guidelines, EASL guidelines update forthcoming in September

EASL guidelines panel, from left to right, is David Back, Xavier Forns, Nancy Reau, Laurent Castera, Jean-Michel Pawlotsky, Alessio Aghemo, Christoph Sarrazin, Massimo Puoti, and Geoffrey Dusheiko. Photo by Liz Highleyman, hivandhepatitis.com

Hepatitis C kills more people than any other infectious disease in US, CDC says